Correlation Between Candel Therapeutics and Spero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Spero Therapeutics, you can compare the effects of market volatilities on Candel Therapeutics and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Spero Therapeutics.
Diversification Opportunities for Candel Therapeutics and Spero Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Candel and Spero is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Spero Therapeutics go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Spero Therapeutics
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 5.51 times more return on investment than Spero Therapeutics. However, Candel Therapeutics is 5.51 times more volatile than Spero Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Spero Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 173.00 in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of 1,178 from holding Candel Therapeutics or generate 680.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Spero Therapeutics
Performance |
| Timeline |
| Candel Therapeutics |
| Spero Therapeutics |
Candel Therapeutics and Spero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Spero Therapeutics
The main advantage of trading using opposite Candel Therapeutics and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Spero Therapeutics vs. Equillium | Spero Therapeutics vs. DiaMedica Therapeutics | Spero Therapeutics vs. Valneva SE ADR | Spero Therapeutics vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Directory Find actively traded commodities issued by global exchanges |